NCT05529316Phase 2Active not recruiting

A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2028-02Estimated

Enrollment · participants150Actual

Source updated2026-01-16Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-01-16 · 1 field changed

Actual enrollment decreased by 24 participants

− Before

~~174 participants (actual)~~

+ After

150 participants (actual)

Check registry source